Home › NDC Lookup › RxCUI directory › RxCUI 617322

Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension — RxCUI 617322

RxNorm drug concept · Semantic clinical drug
RxCUI 617322 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI617322
Official nameAmoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamoxicillin 250 MG / clavulanic acid 62.5 MG per 5 ML Oral Suspension; amoxicillin 250 MG / clavulanic acid 62.5 MG in 5 mL Oral Suspension; amoxicillin (as amoxicillin trihydrate) 250 MG / clavulanic acid (as clavulanate potassium) 62.5 MG per 5 Oral Suspension
FDA products mapped4
Package NDCs mapped12
Reported Medicaid activity (SDUD)90,260 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Amoxicillin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amoxicillin treats bacterial infections — things like ear infections, strep throat, sinus infections, certain respiratory infections, skin infections, and urinary tract infections....
  • What kinds of infections does amoxicillin actually treat?
  • Yes — absolutely finish the full course. Feeling better doesn't mean all the bacteria are gone. If you stop early, any remaining bacteria can rebound, and they may be harder to tre...
  • Do I have to take the whole course even if I feel better after a few days?
📖 Read our full Amoxicillin guide →

🕸️ Concept Web — How Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Or... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension RxCUI 617322

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Amoxicillin 723
    • Clavulanate 48203
    • Amoxicillin / clavulanate 19711
  2. Brand names 5

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Augmentin 151392
    • Betacilin 2692879
    • Clavacillin 2108823
    • Clavamox 897045
    • Umbrellin 2598541
  3. Dose forms 21

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amoxicillin / clavulanate Oral Suspension 617301
    • Amoxicillin / clavulanate Oral Liquid Product 1152873
    • Amoxicillin / clavulanate Oral Product 1152874
    • Amoxicillin / clavulanate Oral Suspension [Augmentin] 617332
    • Amoxicillin / clavulanate Oral Suspension [Betacilin] 2692893
    • Amoxicillin / clavulanate Oral Suspension [Clavacillin] 2668475
    • Amoxicillin / clavulanate Oral Suspension [Clavamox] 897047
    • Amoxicillin / clavulanate Oral Suspension [Umbrellin] 2598555
    • +13 more in this family
  4. Clinical & branded drugs 12

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amoxicillin 50 MG/ML 315370
    • Clavulanate 12.5 MG/ML 617321
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Augmentin] 617339
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Betacilin] 2692894
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Clavacillin] 2668476
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Clavamox] 897048
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Umbrellin] 2598556
    • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Augmentin] 617338
    • +4 more in this family

Showing up to 8 concepts per family — 24 of 41 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amoxicillin 50 MG/ML SCDC · 315370
  • Clavulanate 12.5 MG/ML SCDC · 617321
  • Amoxicillin / clavulanate Oral Suspension SCDF · 617301
  • Amoxicillin / clavulanate Oral Liquid Product SCDG · 1152873
  • Amoxicillin / clavulanate Oral Product SCDG · 1152874

Brand-Name Concepts

  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Augmentin] SBD · 617339
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Betacilin] SBD · 2692894
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Clavacillin] SBD · 2668476
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Clavamox] SBD · 897048
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML Oral Suspension [Umbrellin] SBD · 2598556
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Augmentin] SBDC · 617338
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Betacilin] SBDC · 2692891
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Clavacillin] SBDC · 2668473
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Clavamox] SBDC · 897046
  • Amoxicillin 50 MG/ML / clavulanate 12.5 MG/ML [Umbrellin] SBDC · 2598553

📦 FDA Products & Package NDCs

4 products · 12 package NDCs
12 package NDCs map to RxCUI 617322 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59651-0025-01 100 mL in 1 BOTTLE (59651-025-01) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
59651-0025-55 150 mL in 1 BOTTLE (59651-025-55) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
59651-0025-75 75 mL in 1 BOTTLE (59651-025-75) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
59651-0026-01 100 mL in 1 BOTTLE (59651-026-01) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
59651-0026-55 150 mL in 1 BOTTLE (59651-026-55) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
59651-0026-75 75 mL in 1 BOTTLE (59651-026-75) Amoxicillin and Clavulanate Potassium Aurobindo Pharma Limited 2019-04-19
69097-0098-08 150 mL in 1 BOTTLE (69097-098-08) Amoxicillin and Clavulanate potassium Cipla USA Inc. 2024-10-28
69097-0098-43 75 mL in 1 BOTTLE (69097-098-43) Amoxicillin and Clavulanate potassium Cipla USA Inc. 2024-10-28
69097-0098-44 100 mL in 1 BOTTLE (69097-098-44) Amoxicillin and Clavulanate potassium Cipla USA Inc. 2024-10-28
73043-0010-01 75 mL in 1 BOTTLE (73043-010-01) amoxicillin and clavulanate potassium Devatis, Inc. 2024-08-15
73043-0010-02 100 mL in 1 BOTTLE (73043-010-02) amoxicillin and clavulanate potassium Devatis, Inc. 2024-09-01
73043-0010-03 150 mL in 1 BOTTLE (73043-010-03) amoxicillin and clavulanate potassium Devatis, Inc. 2024-07-05
Observed labelers: Aurobindo Pharma Limited (6) · Cipla USA Inc. (3) · Devatis, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.